Correlation Between Biocardia and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Biocardia and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biocardia and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biocardia and Cue Biopharma, you can compare the effects of market volatilities on Biocardia and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biocardia with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biocardia and Cue Biopharma.
Diversification Opportunities for Biocardia and Cue Biopharma
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Biocardia and Cue is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Biocardia and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Biocardia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biocardia are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Biocardia i.e., Biocardia and Cue Biopharma go up and down completely randomly.
Pair Corralation between Biocardia and Cue Biopharma
Given the investment horizon of 90 days Biocardia is expected to generate 0.74 times more return on investment than Cue Biopharma. However, Biocardia is 1.36 times less risky than Cue Biopharma. It trades about 0.11 of its potential returns per unit of risk. Cue Biopharma is currently generating about 0.01 per unit of risk. If you would invest 215.00 in Biocardia on December 28, 2024 and sell it today you would earn a total of 65.00 from holding Biocardia or generate 30.23% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Biocardia vs. Cue Biopharma
Performance |
Timeline |
Biocardia |
Cue Biopharma |
Biocardia and Cue Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Biocardia and Cue Biopharma
The main advantage of trading using opposite Biocardia and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biocardia position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.Biocardia vs. Aerovate Therapeutics | Biocardia vs. Adagene | Biocardia vs. Acrivon Therapeutics, Common | Biocardia vs. Rezolute |
Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Anixa Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |